UB Paderborn / Katalog / Suche / in CDI

1 – 17 von 17

Sortiert nach

Genetic analysis of fluvastatin response and dyslipidemia in renal transplant recipients

Journal of lipid research, 2007-09, Vol.48 (9), p.2072-2078

2007

Volltextzugriff (PDF)

Effects of a Novel Aldosterone Synthase Inhibitor for Treatment of Primary Hypertension: Results of a Randomized, Double-Blind, Placebo- and Active-Controlled Phase 2 Trial

Circulation (New York, N.Y.), 2011-11, Vol.124 (18), p.1945-1955

2011

Volltextzugriff (PDF)

OPTIMAL DESIGNS FOR DOSE RESPONSE CURVES WITH COMMON PARAMETERS

The Annals of statistics, 2017-10, Vol.45 (5), p.2102-2132

2017

Volltextzugriff (PDF)

Choice of estimand and analysis methods in diabetes trials with rescue medication

Pharmaceutical statistics : the journal of the pharmaceutical industry, 2015-11, Vol.14 (6), p.433-447

2015

Volltextzugriff (PDF)

Poster: CT-121: Phase 3 Study of the Efficacy and Safety of Iptacopan (LNP023), an Oral Factor B Inhibitor, in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Naïve to Complement Inhibitor Therapy

Clinical lymphoma, myeloma and leukemia, 2021-09, Vol.21, p.S259-S259

2021

Volltextzugriff (PDF)

CT-121: Phase 3 Study of the Efficacy and Safety of Iptacopan (LNP023), an Oral Factor B Inhibitor, in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Naïve to Complement Inhibitor Therapy

Clinical lymphoma, myeloma and leukemia, 2021-09, Vol.21, p.S450-S450

2021

Volltextzugriff (PDF)

CT-118: PH3 Study of Efficacy and Safety of Iptacopan (LNP023), an Oral Complement Factor B Inhibitor, in Patients with Paroxysmal Nocturnal Hemoglobinuria and Residual Anemia Despite Anti-C5 Antibody Treatment

Clinical lymphoma, myeloma and leukemia, 2021-09, Vol.21, p.S449-S450

2021

Volltextzugriff (PDF)

Poster: CT-118: PH3 Study of Efficacy and Safety of Iptacopan (LNP023), an Oral Complement Factor B Inhibitor, in Patients with Paroxysmal Nocturnal Hemoglobinuria and Residual Anemia Despite Anti-C5 Antibody Treatment

Clinical lymphoma, myeloma and leukemia, 2021-09, Vol.21, p.S259-S259

2021

Volltextzugriff (PDF)

International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT-HF): rationale for and design of a global registry

European journal of heart failure, 2015-05, Vol.17 (5), p.527-533

2015

Volltextzugriff (PDF)

Parental Smoking, Urinary Cotinine, and Wheezing Bronchitis in Children

Epidemiology (Cambridge, Mass.), 1995-05, Vol.6 (3), p.289-293

1995

Volltextzugriff (PDF)

What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? : Experiences from the metoprolol controlled release/extended release randomized intervention trial in chronic heart failure (MERIT-HF)

Journal of the American College of Cardiology, 2005-01, Vol.45 (2), p.252-259

2005

Volltextzugriff (PDF)

Response to Letter to Regarding Article, “Effects of Novel Aldosterone Synthase Inhibitor for Treatment of Primary Hypertension: Results of a Randomized, Double-Blind, Placebo- and Active-Controlled Phase 2 Trial”

Circulation (New York, N.Y.), 2012-05, Vol.125 (18)

2012

Volltextzugriff (PDF)

Effects of Angiotensin Type-1 Receptor Antagonism on Small Artery Function in Patients With Type 2 Diabetes Mellitus

Hypertension (Dallas, Tex. 1979), 2005-02, Vol.45 (2), p.264-269

2005

Volltextzugriff (PDF)

Skeletal muscle endurance training improves peripheral oxidative capacity, exercise tolerance, and health-related quality of life in women with chronic congestive heart failure secondary to either ischemic cardiomyopathy or idiopathic dilated cardiomyopathy

The American journal of cardiology, 1997-10, Vol.80 (8), p.1025-1029

1997

Volltextzugriff (PDF)

Genetic analysis of fluvastatin response and dyslipidemia in renal transplant recipientss

Journal of lipid research, 2007-09, Vol.48 (9), p.2072-2078

2007

Volltextzugriff (PDF)

What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker?

Journal of the American College of Cardiology, 2005-01, Vol.45 (2), p.252-259

2005

Volltextzugriff (PDF)

Estimation and inference in bivariate and multivariate ordinal probit models

Bermann, Georgina

1993

Volltextzugriff (PDF)

1 – 17 von 17

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(16)
Dissertationen
(1)

Sprache

Englisch
(17)
Japanisch
(2)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Genetic analysis of fluvastatin response and dyslipidemia in renal transplant recipients

Effects of a Novel Aldosterone Synthase Inhibitor for Treatment of Primary Hypertension: Results of a Randomized, Double-Blind, Placebo- and Active-Controlled Phase 2 Trial

OPTIMAL DESIGNS FOR DOSE RESPONSE CURVES WITH COMMON PARAMETERS

Choice of estimand and analysis methods in diabetes trials with rescue medication

Poster: CT-121: Phase 3 Study of the Efficacy and Safety of Iptacopan (LNP023), an Oral Factor B Inhibitor, in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Naïve to Complement Inhibitor Therapy

CT-121: Phase 3 Study of the Efficacy and Safety of Iptacopan (LNP023), an Oral Factor B Inhibitor, in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Naïve to Complement Inhibitor Therapy

CT-118: PH3 Study of Efficacy and Safety of Iptacopan (LNP023), an Oral Complement Factor B Inhibitor, in Patients with Paroxysmal Nocturnal Hemoglobinuria and Residual Anemia Despite Anti-C5 Antibody Treatment

Poster: CT-118: PH3 Study of Efficacy and Safety of Iptacopan (LNP023), an Oral Complement Factor B Inhibitor, in Patients with Paroxysmal Nocturnal Hemoglobinuria and Residual Anemia Despite Anti-C5 Antibody Treatment

International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT-HF): rationale for and design of a global registry

Parental Smoking, Urinary Cotinine, and Wheezing Bronchitis in Children

What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? : Experiences from the metoprolol controlled release/extended release randomized intervention trial in chronic heart failure (MERIT-HF)

Response to Letter to Regarding Article, “Effects of Novel Aldosterone Synthase Inhibitor for Treatment of Primary Hypertension: Results of a Randomized, Double-Blind, Placebo- and Active-Controlled Phase 2 Trial”

Effects of Angiotensin Type-1 Receptor Antagonism on Small Artery Function in Patients With Type 2 Diabetes Mellitus

Skeletal muscle endurance training improves peripheral oxidative capacity, exercise tolerance, and health-related quality of life in women with chronic congestive heart failure secondary to either ischemic cardiomyopathy or idiopathic dilated cardiomyopathy

Genetic analysis of fluvastatin response and dyslipidemia in renal transplant recipientss

What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker?

Estimation and inference in bivariate and multivariate ordinal probit models

Suchergebnisse filtern